3 completed, 1 recruiting, 1 unknown. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Hyperkalemia: new trials by email Literature Review of Hyperkalemia trials Research Report on Hyperkalemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adding Urea to the Final Dialysis Fluid Urea in the dialysate - Dysequilibrium Syndrome, ESRD | Phase 1 / Phase 2 | Recruiting | University of California, San Francisco | 20 | 2025-09-16 | 2026-02-12 |
| The Safety and Tolerability of WS016 in Healthy Chinese Volunteers WS016 Single Dose(6g), WS016 Single Dose(12g), WS016 Single Dose(24g) - Hyperkalemia | Phase 1 | Completed | Waterstone Pharmaceutical (Wuhan) Co., LTD. | 66 | 2023-02-13 | 2024-02-28 |
| Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects Tacrolimus, Cyclosporin, Sodium Zirconium Cyclosilicate - Hyperkalaemia | Phase 1 | Completed | AstraZeneca | 62 | 2021-03-30 | 2024-04-05 |
| Potassium Binder in CKD Patients (With Hyperkalemia) (DiPo Trial) Sodium Zirconium Cyclosilicate Oral Product - Chronic Kidney Diseases, Hyperkalemia | Phase 1 | Unknown | Brigham and Women's Hospital | 20 | 2021-03-15 | 2021-02-01 |
| A Safety and Pharmacodynamic Study of Healthy Chinese Subjects Administered Sodium Zirconium Cyclosilicate (ZS) Sodium Zirconium Cyclosilicate (ZS) - Hyperkalemia | Phase 1 | Completed | AstraZeneca | 22 | 2017-10-24 | 2017-12-19 |
Acidosis (1) · Dysequilibrium syndrome (1) · Kidney Diseases (1) · Kidney Failure, Chronic (1) · Renal Insufficiency, Chronic (1)
Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5) · Water-Electrolyte Imbalance (5) · Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Acid-Base Imbalance (1) · Kidney Diseases (1)
sodium zirconium cyclosilicate (2) · Cyclosporine (1) · Tacrolimus (1) · Urea (1)
AstraZeneca (2) · Brigham and Women's Hospital (1) · University of California, San Francisco (1) · Waterstone Pharmaceutical (Wuhan) Co., LTD. (1)
United States (2) · China (1) · Germany (1) · Hong Kong (1)
Lea Borgi, MD, MMSc (1) · Ramin Sam, MD (1) · Thomas Koernicke, Dr (1)